The 6% naturally derived extract is set to be encapsulated for use in patients suffering from treatment-resistant depression under Australia's Authorised Prescriber Scheme, where no serious adverse ...
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health Canada, ...
Psilocybin has appeared in a number of biotech pipelines as the sector investigates whether psychedelics could improve treatment for certain mental health conditions. Relmada Therapeutics’ attempts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results